TruLeaf medical presents a breakthrough technology which enables a fully percutaneous procedure to replace a mitral valve, with no need to open the patient’s chest, yet, in order to make this dramatic change, a paradigm shift is required and a sacred cow is killed.
A two step procedure makes TMVR a reality!
crossing profile is low, procedure is simple, anchoring is excellent, all hemodynamic problems are solved and last but not least Valve life expectancy is the best ever.
Prof. Halkin:
“This technology should hopefully make TMVR simple efficacious and reproducible”
Prof. Kornowski:
“This approach will fit a large number of patients, it will offer simplicity to the operator, very stable anchoring, and consistent results”
TruLeaf has completed a large animal study with very good results and strong proof of concept.
We are now working on the detailed design and preparing for a Human study.
